Likewise, in kidney cancer, De Palma et al. has identified three transcriptomic markers, including GSTA1, DCEBPA, and PCBD1, that are down regulated in urine EVs of ccRCC patients [162]. The gene discussed is PCBD1; the disease is nonpapillary renal cell carcinoma.